Metacrine shares halved as NASH program nixed on mixed bag data and early safety issue
Metacrine shares halved as NASH program nixed on mixed bag [...]
Could cancer drugs address a hard-to-treat lung disease? Researchers say 2 look promising
Could cancer drugs address a hard-to-treat lung disease? Researchers say [...]
Ventyx nabs a $152M upsized IPO to challenge BMS’ Zeposia—and a backer with intimate knowledge of its rival
Ventyx nabs a $152M upsized IPO to challenge BMS’ Zeposia—and [...]
VCs back Leucid to trial CAR-T twist in ovarian cancer patients
VCs back Leucid to trial CAR-T twist in ovarian cancer [...]
Menarini, chased by 3 Big Pharmas, records win in breast cancer phase 3, plots path to FDA
Menarini, chased by 3 Big Pharmas, records win in breast [...]
FDA slaps clinical hold on AstraZeneca cancer drug amid heart safety scare in combo test
FDA slaps clinical hold on AstraZeneca cancer drug amid heart [...]
Chase, after selling last biotech to Allergan, gets cash to start pivotal trials in depression, Parkinson’s
Chase, after selling last biotech to Allergan, gets cash to [...]
Takeda crashes out of Wave discovery pact at cost of $23M
Takeda crashes out of Wave discovery pact at cost of [...]
Princeton and MIT gene-editing pioneers uncover clues for improving CRISPR and other tools
Princeton and MIT gene-editing pioneers uncover clues for improving CRISPR [...]
Injured tumor cells activate immuno-oncology drugs to combat breast cancer and melanoma in mice
Injured tumor cells activate immuno-oncology drugs to combat breast cancer [...]